Schonfeld Strategic Advisors »

Allogene Therapeutics shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $110k 53k 2.08
2024-06-30 $40k 17k 2.33
2023-12-31 $113k 35k 3.21
2023-06-30 $508k 102k 4.97
2022-12-31 $783k 125k 6.29
2022-09-30 $2.9M 264k 10.80
2022-06-30 $1.3M 118k 11.40
2022-03-31 $732k 80k 9.10
2021-09-30 $1.0M 41k 25.68
2021-06-30 $2.7M 104k 26.07
2018-12-31 $269k 10k 26.90

More positions owned by Schonfeld Strategic Advisors

Ishares Tr Core S&p500 Etf (IVV)
Micron Technology (MU)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Msci Brazil Etf (EWZ)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Amazon (AMZN)
Broadcom (AVGO)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vale S A Sponsored Ads (VALE)
Petroleo Brasileiro S A Sponsored Adr (PBR)

View all positions for Schonfeld Strategic Advisors

Top funds holding Allogene Therapeutics

BlackRock
Frazier Life Sciences Management
Pfizer
Tpg Gp A
Sio Capital Management
PRIMECAP Management Company
Vanguard Capital Management
FMR
Citadel Advisors
State Street Corporation
Two Sigma Investments
Geode Capital Management
Goldman Sachs Group
T. Rowe Price Associates
Marshall Wace

View all funds holding Allogene Therapeutics